Analysts are saying that UnitedHealth Group could hit $312 by 2030. Bullish on UNH? Invest in UnitedHealth Group on SoFi with no commissions. If it’s your first time signing up for SoFi, you’ll receive up to $1,000 in stock when you first fund your account. Plus, get a 1% bonus if you transfer your investments and keep them there until December 31, 2025.
UnitedHealth Group Inc. (UNH) has endured a rough year. A federal investigation into its billing practices, lowered financial guidance, the brutal killing of a top executive, and the departure of its CEO have driven shares down nearly 50% in the last year. Some investors, however, believe the selloff is overdone.
In this article, we’ll look at UNH’s latest share price, Wall Street sentiment, multiyear price forecasts, and the key factors that are playing a critical role in the company’s path going forward.
Current Stock Overview
Market Cap: $289 billion
Trailing P/E Ratio: 13.65
Forward P/E Ratio: 17.92
1-Year Return: -47%
2025 YTD: -37%
UnitedHealth Group shares have lost nearly half their value over the past year and have dropped 37% year-to-date, trading around $320 as of September 2025. The stock has recovered more than 30% from its August lows, but the healthcare company faces an uphill battle after a series of damaging events.
In December 2024, Brian Thompson, CEO of the company’s UnitedHealthcare subsidiary, was shot and killed in New York City, highlighting public outrage for health insurers who’ve been accused of putting profits above patients. In April of 2025, UnitedHealth Group lowered its earnings forecast for the year. In May, CEO Andrew Witty resigned citing “personal reasons.” In July, after months of reports about a possible probe into its Medicare Advantage billing practices, UnitedHealth Group said it was cooperating with a Department of Justice (DOJ) Investigation. Finally in July, the company cut its previous 2025 earnings guidance by nearly half.
Despite the raft of negative news, some investors are viewing the stock’s recent dip as a buying opportunity. In August, Warren Buffett's Berkshire Hathaway provided a much-needed vote of confidence with the purchase of 5 million shares. UnitedHealth is still an established leader in health insurance, and an aging population should boost revenue growth as long as the company can keep losses from claims under control.
UNH has a consensus Buy rating from 26 analysts, according to Benzinga. The average price target is $397.20 per share, which suggests a meaningful 26% gain from current levels. The highest price target is $675, and the lowest is $198. The three most recent ratings suggest a near-term average target of $390.33, suggesting a 22.48% upside.
Quick Snapshot Table of Predictions
Year | Bearish Prediction | Average Prediction | Bullish Prediction |
|---|---|---|---|
2025 | $352.56 | $101.72 | $453.09 |
2026 | $406.30 | $461.78 | $502.00 |
2027 | $408.28 | $452.81 | $498.57 |
2028 | $398.04 | $484.04 | $564.19 |
2029 | $215.29 | $360.59 | $541.26 |
2030 | $363.22 | $412.39 | $447.78 |
The forecast range in this table is based on algorithmic projections provided by CoinCodex. These models use historical price trends, volatility patterns, and moving averages to estimate future stock prices over multiple time horizons.
Bull & Bear Case
UnitedHealth Group has been a roller coaster of a stock over the past year. Scrutiny from the DOJ and potential regulations that can follow may hurt profit margins in the future, but it remains a top health insurer. These are the bull and bear points to consider.
Bull Case
- UnitedHealth’s established leadership in health insurance can help it weather its recent troubles.
- The steep drop in share price has attracted value investors like Warren Buffett
- An aging population could help the company accelerate revenue growth
Bear Case
- A DOJ investigation can impact UnitedHealth Group’s business, and a negative outcome could cut into profits.
- An older population could translate into more claims
- UnitedHealth has sharply reduced its financial guidance for 2025, suggesting growth and profits will slow in the coming year
Stock Price Prediction for 2025
Forecasts for UnitedHealth Group suggest limited movement in the near term, as uncertainty around the DOJ investigation and the stock’s year-to-date decline weigh on sentiment.
Analysts note that these factors may leave little room for major swings in either direction until greater clarity emerges.
Stock Price Prediction for 2026
Outlook for 2026 suggests UnitedHealth could move past its current challenges, with revenue growth supported by an aging population and rising demand for healthcare services.
Forecasts assume the company stabilizes operations and continues expanding its footprint in a growing sector.
Stock Price Prediction for 2030
Long-term projections for UnitedHealth highlight both opportunity and risk. An aging population is expected to boost demand for healthcare services, which could support revenue growth.
At the same time, rising claim volumes may pressure margins, and increased government oversight of Medicare Advantage could limit profitability and weigh on the company’s growth trajectory.
Investment Considerations
UnitedHealth Group shares have been dragged down over the past year as the DOJ’s investigation could lead to financial penalties and operational restrictions. That oversight casts doubts on future growth prospects. The company has slashed its guidance considerably as it tries to navigate this complex environment.
Some investors like Warren Buffett believe the current challenges will not last, however. UnitedHealth Group is still a leading health insurance provider, and an aging population can fuel revenue growth.
Key risks: Regulatory scrutiny hurts UNH’s business, an aging population results in more claims and losses, leadership continues to face volatility, the company struggles to overcome its damaged reputation, and management continues to reduce guidance.
UNH appeals to value investors who believe in buying the dip and waiting for shares to recover, noting that other stocks hurt by scandals went on to reach all-time highs.
Frequently Asked Questions
Is UNH stock a good long-term investment?
UNH is a value stock that may become a long-term investment if it can move past its current challenges and preserve its Medicare Advantage segment. If the government forces UnitedHealth to make meaningful changes to its billing policies, future profits may take a hit.
What will UNH stock be worth in 2030?
CoinCodex projects an average price target of $306.80 per share by 2030, which suggests a slight drop from current levels.
Does UNH stock pay a dividend?
Yes. UNH stock offers a dividend to its investors, and its yield is 2.8% as of September 2025.
About Marc Guberti
Marc Guberti is an investing writer passionate about helping people learn more about money management, investing and finance. He has more than 10 years of writing experience focused on finance and digital marketing. His work has been published in U.S. News & World Report, USA Today, InvestorPlace and other publications.
